Company Novavax, Inc. Nasdaq
Equities
US6700021040
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Vaccines
100.0
%
| 1,982 | 100.0 % | 984 | 100.0 % | -50.36% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1,982 | 100.0 % | 984 | 100.0 % | -50.36% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Jacobs
CEO | Chief Executive Officer | 57 | 23-01-22 |
John Trizzino
PSD | President | 64 | 14-03-09 |
James Kelly
DFI | Director of Finance/CFO | 58 | 21-08-15 |
Troy Morgan
CMP | Compliance Officer | - | 21-04-18 |
Biegie Lee
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Seth Toback
CTO | Chief Tech/Sci/R&D Officer | - | 20-06-30 |
Gale Smith
CTO | Chief Tech/Sci/R&D Officer | - | 03-12-31 |
Raburn Mallory
CTO | Chief Tech/Sci/R&D Officer | - | 19-12-31 |
Silvia Taylor
IRO | Public Communications Contact | - | 20-06-16 |
Erika Schultz
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Rodgers
BRD | Director/Board Member | 57 | 22-10-28 |
Gregg Alton
BRD | Director/Board Member | 58 | 20-10-31 |
David Mott
BRD | Director/Board Member | 58 | 20-06-15 |
James Young
CHM | Chairman | 71 | 10-04-06 |
Margaret McGlynn
BRD | Director/Board Member | 64 | 20-12-06 |
Rachel King
BRD | Director/Board Member | 64 | 18-10-31 |
Richard Douglas
BRD | Director/Board Member | 71 | 10-08-05 |
John Jacobs
CEO | Chief Executive Officer | 57 | 23-01-22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 141,745,693 | 133,406,786 ( 94.12 %) | 1,327,717 ( 0.9367 %) | 94.12 % |
Company contact information
![address Novavax, Inc.](https://cdn.zonebourse.com/static/address/10281.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+22.52% | 45.01B | |
+47.19% | 40.96B | |
-5.10% | 38.62B | |
+34.84% | 32.6B | |
-8.34% | 27.49B | |
+18.78% | 27.17B | |
+48.71% | 14.61B | |
+40.34% | 12.95B | |
-3.00% | 11.36B |